Posts Tagged ‘MRSA’

 Page 1 of 2  1  2 »

Medizone To Launch AsepticSure In August

Medizone International, Inc. announced that its highly-acclaimed, ozone-based decontamination and infection control technology, AsepticSure™, will be officially launched at one of the world’s premier medical expo events – FIME Miami – on August 10–12, 2011 at the Miami Beach Convention... (Continue reading)

Marshall-Tufflex’s Antimicrobial Systems Good For The Public Sector

Marshall-Tufflex's Antimicrobial Systems Good For The Public Sector

Reducing the risk of hospital-acquired infections is a top priority for the National Health Service – not only do such infections pose a real and high risk to health, National Audit Office figures calculate they cost the NHS up to... (Continue reading)

Ecolab Launches First EPA-Approved, Ready-to-Use Hard Surface Disinfectant Effective against Clostridium Difficile

Ecolab Launches First EPA-Approved, Ready-to-Use Hard Surface Disinfectant Effective against Clostridium Difficile

Ecolab Inc. today announced the launch of Virasept(TM), Ecolab’s first ready-to-use (no mixing required) hard surface disinfectant approved by the U.S. Environmental Protection Agency to be effective against Clostridium difficile spores. Clostridium difficile is a highly drug-resistant bacterium that causes diarrhea... (Continue reading)

Tagged with:                                             

Orbio Technologies and Activeion Cleaning Solutions LLC kill bacteria cells without using chemicals

Orbio Technologies and Activeion Cleaning Solutions LLC kill bacteria cells without using chemicals

Orbio Technologies, Tennant Company’s chemical-free technology arm, announced today that working together with their license partner Activeion, they have discovered the ability to kill bacterial cells and inactivate pathogenic viruses without using chemicals. The technology, which is based on irreversible... (Continue reading)

Tagged with:                                                                                                             

U.S. Army Awards $2.73 Million To Synedgen for Development of Molecules That Kill Drug-Resistant Bacteria

U.S. Army Awards $2.73 Million To Synedgen for Development of Molecules That Kill Drug-Resistant Bacteria

Synedgen, Inc. has been awarded $2.73 million in funding by the U.S. Army for development of life-saving products and therapies to treat drug-resistant bacteria, particularly those that threaten U.S. troops injured in the battlefield. The award will be used to manufacture... (Continue reading)

Essential oils to fight superbugs

Essential oils to fight superbugs

ssential oils could be a cheap and effective alternative to antibiotics and potentially used to combat drug-resistant hospital superbugs, according to research presented at the Society for General Microbiology’s spring meeting in Edinburgh this week. Professor Yiannis Samaras and Dr... (Continue reading)

Revolutionary Technology to Eliminate Superbugs

Revolutionary Technology to Eliminate Superbugs

A revolutionary new device is being launched today with the technology to eradicate up to 99.9999% of pathogenic airborne and surface bacteria and viruses. The Cirrus3, powered by technology from British company Tri-Air Developments, has been proven by a government agency... (Continue reading)

Clean Room Silicone Sealant

Dow Corning 798+ protects against bacteria growth, MRSA, E. Coli and Salmonella. It is a one part, flexible, fast curing silicone rubber sealant specifically designed for the sealing of refrigeration units and areas where intermittent contact with food is likely MAIN... (Continue reading)

AsepticSure™ Hospital Sterilization System Demonstrates Total Eradication of Super Bugs

AsepticSure™ Hospital Sterilization System Demonstrates Total Eradication of Super Bugs

Medizone International, Inc. (MZEI.OB) announced today that every full scale test run completed thus far in its hospital room mock up facility has resulted in the total elimination of all bacteria present in the room. In this current phase of development,... (Continue reading)

Tagged with:                                                 

Isogenica and the Defence Science and Technology Laboratory develop antimicrobial peptide drugs with potential to treat MRSA

Isogenica and the Defence Science and Technology Laboratory develop antimicrobial peptide drugs with potential to treat MRSA

Isogenica Ltd today announced that it has entered into an agreement with UK Ministry of Defence agency, the Defence Science and Technology Laboratory (Dstl). The agreement concerns the development of antimicrobial peptide drugs and follows a successful collaboration to identify... (Continue reading)

Tagged with:                                                                     
 Page 1 of 2  1  2 »